SHARI L GERMSCHEID NP NPI 1962485680

NPI Details

Shari L Germscheid, NP is a family nurse practitioner in Maple Grove, MN with 27 years of experience. Shari L Germscheid, NP NPI is 1962485680. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

6320 WEDGEWOOD RD N
MAPLE GROVE, MN
ZIP 55311-647
Phone: (763) 268-0400

The NPI 1962485680 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Transfusion of blood or blood products (HCPCS:36430)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Blood typing for rh (d) antigen (HCPCS:86901)
• Screening test for red blood cell antibodies (HCPCS:86850)
• Blood group typing (abo) (HCPCS:86900)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Magnesium level (HCPCS:83735)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Collection of blood sample from implanted device (HCPCS:36591)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Unclassified drugs (HCPCS:J3490)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood creatinine level (HCPCS:82565)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Total protein level, blood (HCPCS:84155)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)

The enumeration date for this NPI number is 11/28/2005 and was last updated on 7/19/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.